Ukrainian army violates ceasefire 45 times over past 24 hours — DPR Defense Ministry
Russian specialists will dismantle equipment on Mistral warships in September — source
Russian Baltic Fleet’s naval aviation starts missile firing exercises near Kaliningrad
Batch of coal supplied to energy-starved Ukraine from South Africa — official
Dollar and euro down against the ruble at opening of trade
Ukrainian army violates ceasefire 45 times over past 24 hours — DPR Defense MinistryWorld August 04, 14:42
Russian Baltic Fleet’s naval aviation starts missile firing exercises near KaliningradRussia August 04, 14:31
Donetsk republic urges Kiev to adopt constructive approach during talksWorld August 04, 14:21
More than 25 people on international wanted list extradited to Russia in 2015Russia August 04, 14:03
Moscow concerned with expanding influence of Islamic State — Kremlin spokesmanWorld August 04, 13:57
Mariinsky Theater stars to perform at China youth arts festivalNon-political August 04, 13:47
Russian Pacific Fleet coastal defense troops drills to be held in Kamchatka in late AugustRussia August 04, 13:44
Chief of Vatican’s diplomacy calls for walking in step with RussiaWorld August 04, 13:27
Batch of coal supplied to energy-starved Ukraine from South Africa — officialEconomy August 04, 13:19
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.